* Privia Health Group Inc PRVA.OQ PRVA.O is expected
to show a
rise in quarterly revenue when it reports results on August 8
for the period ending June 30 2024
* The Arlington Virginia-based company is expected to
report a
0.9% increase in revenue to $706.445 million from $700 million a
year ago, according to the mean estimate from 13 analysts, based
on LSEG data. (Revenue consensus is on Total practice
collection(non- gaap))
* LSEG's mean analyst estimate for Privia Health Group Inc
is for
earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 19 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Privia
Health
Group Inc is $25.00, above its last closing price of $19.26.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 0.05 0.05 0.02 Missed -58
Jan. 1 2024 0.04 0.04 0.02 Missed -52.7
Sep. 30 2023 0.05 0.05 0.05 Met 0
Jun. 30 2023 0.06 0.06 0.06 Met 7.4
Jan. 0.03 0.02 0.06 Beat 228.8
1 0001
Dec. 31 2022 -0.03 -0.03 0.14 Beat 606.5
Sep. 30 2022 0.00 0.00 0.01 Beat 109.2
Jan. 1 0001 -0.02 -0.03 0.14 Beat 636.2
This summary was machine generated August 6 at 18:52 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)